Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Notes)

Acquisition (Notes)
9 Months Ended
Sep. 30, 2013
Acquisition [Abstract]  
Acquisition: AcariaHealth, Inc.

In April 2013, the Company acquired 100% of AcariaHealth, Inc., a specialty pharmacy company, for $142,495 in total consideration. The transaction consideration was financed through a combination of $75,425 of Centene common stock and $67,070 of cash on hand. The Company subsequently sold 342,640 shares of common stock for $15,225 related to funding the escrow account for the acquisition.

The Company's allocation of fair value resulted in goodwill of $91,260 and other identifiable intangible assets of $35,000. The goodwill is not deductible for income tax purposes. The acquisition is recorded in the Specialty Services segment.